![](/img/cover-not-exists.png)
452P Disease progression site and subsequent therapy after progression during alectinib therapy
Murakami, H., Omori, S., Nakashima, K., Wakuda, K., Ono, A., Kenmotsu, H., Naito, T., Takahashi, T.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.016
Date:
December, 2016
File:
PDF, 82 KB
2016